World EBHC Day launches campaign to address global health challenges through partnerships for purpose
Led by JBI at the University of Adelaide, an alliance of global leaders in evidence-based healthcare join forces to shine a light on partnerships that bridge research, policy and practice to improve health outcomes globally.
JBI, Cochrane, Campbell, GIN, the Institute for Evidence-Based Healthcare, the Centre for Evidence-based Health Care and NICE recently launched the World EBHC Day 2022 campaign, ‘Partnerships for Purpose’.
The 2022 campaign aims to examine partnerships and practical considerations around establishing different types of partnerships, accelerating innovation, ensuring equity and integrity, overcoming challenges and biases, lessons learned and achieving impact for improved health outcomes globally.
‘The global evidence community has long recognised that collaboration is key to producing trustworthy, pragmatic evidence. The global COVID-19 pandemic has highlighted the importance of evidence-based healthcare and the need for partnerships in developing rapid evidence-informed responses, streamlining global efforts, reducing research waste, and ensuring the best-available evidence is accessible, transparent and understood’, explains Bianca Pilla, World EBHC Day Committee Chair.
The scale of national and international collaboration triggered by COVID-19 has surpassed all historical precedents. While many partnerships existed before the pandemic, there has been an extraordinary increase in new and innovative partnerships and collaboration between regulators, governments, scientists and researchers, healthcare providers, tech giants and consumer groups – many of which were written about in the blogs published for World EBHC Day 2021
There is a growing concern, which was heightened during the pandemic, about making partnerships and collaboration equitable for — and beneficial to — all partners. Although willingness to collaborate has increased, vested interests, bureaucracy and inability to change remain limiting factors. Around the globe, organisations have set up networks, task forces and working groups to coordinate efforts and overcome some of these challenges.
‘There is a strong ethical imperative for groups like JBI to work with global partners to ensure the best evidence is available to inform decision-making. Despite the grave difficulties associated with working remotely across geographically dispersed groups and time zones, the pandemic has also highlighted the significant benefits of these relationships and made us acutely aware of the need to find ways of supporting each other for the common good.’ Says JBI Executive Director, Prof Zoe Jordan.
World EBHC Day 2022 seeks to raise awareness, stimulate debate and shine a light on best practice in the science and art of working in partnership to bridge research, policy and practice, and realise the potential of evidence-based healthcare.
World EBHC Day calls on individuals and organisations around the world to take action as we lead up to World EBHC Day on 20 October. Visit https://worldebhcday.org and contribute to a global discussion on how to partner for purpose to address global health challenges.
About World Evidence-Based Healthcare Day
World Evidence-Based Healthcare (EBHC) Day is held on 20 October each year. It is a global initiative that raises awareness of the need for better evidence to inform healthcare policy, practice and decision making in order to improve health outcomes globally. It is an opportunity to participate in debate about global trends and challenges, but also to celebrate the impact of individuals and organisations worldwide, recognising the work of dedicated researchers, policymakers and health professionals in improving health outcomes. World EBHC Day is delivered with the generous support of Principal Sponsor, Wolters Kluwer Health.
For more information, please visit: https://worldebhcday.org
Media contact:
Bianca Pilla, World Evidence-Based Healthcare (EBHC) Day Committee Chair
Mobile: +61 (0)404 893 324, [email protected]